| 000 -LEADER |
|---|
| fixed length control field |
01635 a2200313 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
040419s xx 000 0 eng |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
|---|
| International Standard Serial Number |
1522-3221; |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
AC1.S5 |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
050 |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Concar, David, |
| 245 #2 - TITLE STATEMENT |
|---|
| Title |
A Bitter Pill. |
| Statement of responsibility, etc. |
David Concar. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Name of publisher, distributor, etc. |
Amnesty Now, |
| Date of publication, distribution, etc. |
2003. |
| 440 ## - SERIES STATEMENT/ADDED ENTRY--TITLE |
|---|
| Title |
SIRS Enduring Issues 2004. |
| Number of part/section of a work |
Article 71, |
| Name of part/section of a work |
Global Issues, |
| International Standard Serial Number |
1522-3221; |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Articles Contained in SIRS Enduring Issues 2004. |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Originally Published: A Bitter Pill, Summer 2003; pp. 10+. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
"Shoe and clothing companies were among the first to seek out the cheap labor, tax breaks, and looser regulations of developing countries in the recent wave of globalization. Pharmaceutical companies discovered that they, too, could save money and time by moving the costliest part of their business--clinical trials--overseas." (AMNESTY NOW) The author examines the practices of pharmaceutical companies and suggests that the "side effects of globalizing human experimentation may include questionable ethics, preventable deaths and violations of international agreements." |
| 599 ## - |
|---|
| -- |
Records created from non-MARC resource. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Clinical trials |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drugs |
| General subdivision |
Testing |
| 610 ## - SUBJECT ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
Eli Lilly and Company |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Globalization |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Human experimentation in medicine |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Medical care |
| Geographic subdivision |
Developing countries |
| 610 ## - SUBJECT ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
Pfizer Inc. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmaceutical ethics |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmaceutical industry |
| 710 ## - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
ProQuest Information and Learning Company |
| Title of a work |
SIRS Enduring Issues 2004, |
| Name of part/section of a work |
Global Issues. |
| International Standard Serial Number |
1522-3221; |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
|
